Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2012, Vol. 32 Issue (02): 107-116    DOI:
    
Endoglycosidase-based Chemoenzymatic Synthesis of Homogeneous Glycopeptides and Glycoproteins Carrying Defined N-Glycans
ZOU Yang1,2, XUE Meng-yang1,2, ZHAO Ying-hua1, CHEN Min1,2
1. The State Key Laboratory of Microbial Technology, Shandong University, Jinan 250100, China;
2. National Glycoengineering Research Center, Shandong University, Jinan 250100, China
Download: HTML   PDF(905KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Protein glycosylation is the important step involved in post-translational modifications within eukaryotes, and it plays a significant role in protein folding and transportational processes. The oligosaccharide moieties of glycoconjugates have a major impact on the structure and functions of protein, and influence biological phenomena such as lectin binding, viral infection and cellular recognition. In the field of glycobiology, it is necessary to investigate the homogeneous glycopeptides and glycoprotein for detailed structural and functional studies of glycoproteins. As a result, how to synthesize this kind of glycoprotein and glycopeptides efficiently has become an important subject in glycotechnology. At the present time, three major strategies have been developed to synthesize homogeneous glycopeptides. One is using pre-formed glycosyl amino acids as building blocks in solid-phase or solution-phase peptide synthesis. Another strategy is combining an oligosaccharide glycosylamine with a pre-assembled polypeptide which contains a free or selectively activated aspartyl side chain to synthesize glycoprotein. The main disadvantages of these approaches are that the strong acidic conditions may cause partial hydrolysis of the attached oligosaccharide moiety. To deal with these problems mentioned in the above strategies, a new chemoenzymatic approach combined with endoglycosidase which from microorganisms to synthesize homogeneous glycopeptides is developed. This approach requires only monosaccharide-tagged polypeptides, and the reaction condition is very moderate. The sugar chain extension is combined with free polypeptides in aqueous solutions, without the using of protecting groups. Both glycosyltransferases and endoglycosidases have been explored for this chemoenzymatic strategy. Compared with glycosyltransferase-based methods, the endoglycosidase-based approach is more attractive because it can connect a large intact oligosaccharide to a GlcNAc polypeptide in one-step. Although this endoglycosidase-based chemoenzymatic approach is better than other methods, it still has shortcomings, such as low transglycosylation efficiency and product hydrolysis issue. The synthesis of these homogeneous glycopeptides is still a challenging work because of every strategy has its own advantages and limitations. But compared with other strategies, endoglycosidase-based chemoenzymatic synthetic approach is more attractive owing to its faster developing and more practical significance. Following aspects are focused on: the research progress of endoglycosidase-based chemoenzymatic synthetic strategy, including 4 aspects: (1) Studies on the catalytic mechanism of endoglycosidase. Such as substrate-assisted mechanism. (2) Researches of glycosyl donors of endoglycosidase. Based on the substrate-assisted mechanism of ENGase-catalyzed reaction proceed, sugar oxazolines was used as activated substrates for ENGase-catalyzed transglycosylation, and this substrate surprisingly induced substantial improvement of the synthetic efficiency and high-yield of large glycopeptides. (3) Investigations of mutants of endoglycosidase. Which lack hydrolytic activity but can still combine an activated glycosyl donor to peptide acceptor for catalysis to form a new glycosidic bond. (4) The applications of glycoprotein and glycopeptides which have homogeneous sugar chains and synthesized by endoglycosidase-based chemoenzymatic approaches. These glycoproteins could be used in the study of structure-function relationship of protein, and the study of modifications of protein glycosylation.



Key wordsGlycoprotein      Glycopeptides      Chemoenzymatic synthesis      Endo-β-N-acetylglucosaminidase      Oligosaccharide oxazoline     
Received: 09 November 2011      Published: 25 February 2012
ZTFLH:  Q5  
  Q81  
  Q93  
Cite this article:

ZOU Yang, XUE Meng-yang, ZHAO Ying-hua, CHEN Min. Endoglycosidase-based Chemoenzymatic Synthesis of Homogeneous Glycopeptides and Glycoproteins Carrying Defined N-Glycans. China Biotechnology, 2012, 32(02): 107-116.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2012/V32/I02/107


[1] Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science, 2001, 291(5512):2364-2369.

[2] Petrescu A J, Wormald M R, Dwek R A. Structural aspects of glycomes with a focus on N-glycosylation and glycoprotein folding. Curr Opin Struct Biol, 2006, 16(5):600-607.

[3] Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology, 1993, 3(2):97-130.

[4] Dwek R A. Glycobiology: Toward understanding the function of sugars. Chem Rev, 1996, 96(2):683-720.

[5] Dwek R A, Butters T D, Platt F M, et al. Targeting glycosylation as a therapeutic approach. Nat Rev Drug Discov, 2002, 1(1):65-75.

[6] Haltiwanger R S, Lowe J B. Role of glycosylation in development. Annu Rev Biochem, 2004, 73:491-537.

[7] Dube D H, Bertozzi C R. Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat Rev Drug Discov, 2005, 4(6):477-488.

[8] Grogan M J, Pratt M R, Marcaurelle L A, et al. Homogeneous glycopeptides and glycoproteins for biological investigation. Annu Rev Biochem, 2002, 71:593-634.

[9] Davis B G. Synthesis of glycoproteins. Chem Rev, 2002, 102(2):579-602.

[10] Buskas T, Ingale S, Boons G J. Glycopeptides as versatile tools for glycobiology. Glycobiology, 2006, 16(8):113-136.

[11] Kajihara Y, Yamamoto N, Miyazaki T, et al. Synthesis of diverse asparagine linked oligosaccharides and synthesis of sialylglycopeptide on solid phase. Curr Med Chem, 2005, 12(5):527-550.

[12] Hojo H, Matsumoto Y, Nakahara Y, et al. Chemical synthesis of 23 kDa glycoprotein by repetitive segment condensation: a synthesis of MUC2 basal motif carrying multiple O-GalNAc moieties. J Am Chem Soc, 2005, 127(39):13720-13725.

[13] Yamamoto N, Tanabe Y, Okamoto R, et al. Chemical synthesis of a glycoprotein having an intact human complex-type sialyloligosaccharide under the Boc and Fmoc synthetic strategies. J Am Chem Soc, 2008, 130(2):501-510.

[14] Roberge J Y, Beebe X, Danishefsky S J. A strategy for a convergent synthesis of N-linked glycopeptides on a solid support. Science, 1995, 269(5221):202-204.

[15] Miller J S, Dudkin V Y, Lyon G J, et al. Toward fully synthetic N-linked glycoproteins. Angew Chem Int Ed Engl, 2003, 42(4):431-434.

[16] Kaneshiro C M, Michael K. A convergent synthesis of N-glycopeptides. Angew Chem Int Ed Engl, 2006, 45(7):1077-1081.

[17] Mandal M, Dudkin V Y, Geng X, et al. In pursuit of carbohydrate-based HIV vaccines, part 1: The total synthesis of hybrid-type gp120 fragments. Angew Chem Int Ed Engl, 2004, 43(19):2557-2561.

[18] Geng X, Dudkin V Y, Mandal M, et al. In pursuit of carbohydrate-based HIV vaccines, part 2: The total synthesis of high-mannose-type gp120 fragments-evaluation of strategies directed to maximal convergence. Angew Chem Int Ed Engl, 2004, 43(19):2562-2565.

[19] Dudkin V Y, Miller J S, Danishefsky S J. Chemical synthesis of normal and transformed PSA glycopeptides. J Am Chem Soc, 2004, 126(3):736-738.

[20] Warren J D, Miller J S, Keding S J, et al. Toward fully synthetic glycoproteins by ultimately convergent routes: a solution to a long-standing problem. J Am Chem Soc, 2004, 126(21):6576-6578.

[21] Bennett C S, Dean S M, Payne R J, et al. Sugar-assisted glycopeptide ligation with complex oligosaccharides: scope and limitations. J Am Chem Soc, 2008, 130(36):11945-11952.

[22] Wang L X. Chemoenzymatic synthesis of glycopeptides and glycoproteins through endoglycosidase-catalyzed transglycosylation. Carbohydr Res, 2008, 343(10-11):1509-1522.

[23] Guo Z, Shao N. Glycopeptide and glycoprotein synthesis involving unprotected carbohydrate building blocks. Med Res Rev, 2005, 25(6):655-678.

[24] Muthana S, Cao H, Chen X. Recent progress in chemical and chemoenzymatic synthesis of carbohydrates. Curr Opin Chem Biol, 2009, 13(5-6): 573-581.

[25] Yamamoto K. Chemo-enzymatic synthesis of bioactive glycopeptide using microbial endoglycosidase. J Biosci Bioeng, 2001, 92(6):493-501.

[26] Tarentino A L, Plummer T H. Enzymatic deglycosylation of asparagines-linked glycans: purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum. Methods Enzymol, 1994, 230:44-57.

[27] Kato T, Fujita K, Takeuchi M, et al. Identification of an endo-beta-N-acetylglucosaminidase gene in Caenorhabditis elegans and its expression in Escherichia coli. Glycobiology, 2002, 12(10):581-587.

[28] Suzuki T, Yano K, Sugimoto S, et al. Endo-beta-N-acetylglucosaminidase, an enzyme involved in processing of free oligosaccharides in the cytosol. Proc Natl Acad Sci U S A, 2002, 99(15):9691-9696.

[29] Robbins PW, Trimble R B, Wirth D F, et al. Primary structure of the Streptomyces enzyme endo-beta-N-acetylglucosaminidase H. J Biol Chem, 1984, 259(12):7577-7583.

[30] Tarentino A L, Quinones G, Schrader W P, et al. Multiple endoglycosidase (Endo) F activities expressed by Flavobacterium meningosepticum. Endo F1: molecular cloning, primary sequence, and structural relationship to Endo H. J Biol Chem, 1992, 267(6):3868-3872.

[31] Tarentino A L, Quinones G, Changchien L M, et al. Multiple endoglycosidase F activities expressed by Flavobacterium meningosepticum endoglycosidases F2 and F3. Molecular cloning, primary sequence, and enzyme expression. J Biol Chem, 1993, 268(13):9702-9708.

[32] Yamamoto K, Kadowaki S, Watanabe J, et al. Transglycosylation activity of Mucor hiemalis endo-beta-N-acetyl-glucosaminidase which transfers complex oligosaccharides to the N-acetylglucosamine moieties of peptides. Biochem Biophys Res Commun, 1994, 203(1):244-252.

[33] Takegawa K, Yamaguchi S, Kondo A, et al. Transglycosylation activity of endo-beta-N-acetylglucosaminidase from Arthrobacter protophormiae. Biochem Int, 1991, 24(5):849-855.

[34] Takegawa K, Yamaguchi S, Kondo A, et al. Enzymatic synthesis of novel oligosaccharides by use of transglycosylation activity of endo-beta-N-acetylglucosaminidase from Arthrobacter protophormiae. Biochem Int, 1991, 25(5):829-835.

[35] Muramatsu H, Tachikui H, Ushida H, et al. Molecular cloning and expression of endo-beta-N-acetylglucosaminidase D, which acts on the core structure of complex type asparagines-linked oligosaccharides. J Biochem, 2001, 129(6):923-928.

[36] Fujita K, Takami H, Yamamoto K, et al. Characterization of endo-beta-N-acetylglucosaminidase from alkaliphilic Bacillus halodurans C-125. Biosci Biotechnol Biochem, 2004, 68(5):1059-1066.

[37] Tarentino A L, Maley F. Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus. J Biol Chem, 1974, 249(3):811-817.

[38] Mizuno M, Haneda K, Iguchi R, et al. Synthesis of a glycopeptide containing oligosaccharides: Chemoenzymatic synthesis of eel calcitonin analogues having natural N-linked oligosaccharides. J Am Chem Soc, 1999, 121:284-290.

[39] Haneda K, Inazu T, Mizuno M, et al. Chemo-enzymatic synthesis of a bioactive peptide containing a glutamine-linked oligosaccharide and its characterization. Biochim Biophys Acta, 2001, 1526(3):242-248.

[40] Singh S, Ni J, Wang L X. Chemoenzymatic synthesis of high-mannose type HIV-1 gp120 glycopeptides. Bioorg Med Chem Lett, 2003, 13(3):327-330.

[41] Wang L X, Song H, Liu S, et al. Chemoenzymatic synthesis of HIV-1 gp41 glycopeptides: effects of glycosylation on the anti-HIV activity and alpha-helix bundle-forming ability of peptide C34. Chembiochem, 2005, 6(6):1068-1074.

[42] Li H, Singh S, Zeng Y, et al. Chemoenzymatic synthesis of CD52 glycoproteins carrying native N-glycans. Bioorg Med Chem Lett, 2005, 15(4):895-898.

[43] Akaike E, Tsutsumida M, Osumi K, et al. High efficiency of transferring a native sugar chain from a glycopeptide by a microbial endoglycosidase in organic solvents. Carbohydr Res, 2004, 339(3):719-722.

[44] Brameld K A, Shrader W D, Imperiali B, et al. Substrate assistance in the mechanism of family 18 chitinases: theoretical studies of potential intermediates and inhibitors. J Mol Biol, 1998, 280(5):913-923.

[45] Williams S J, Mark B L, Vocadlo D J, et al. Aspartate 313 in the Streptomyces plicatus hexosaminidase plays a critical role in substrate-assisted catalysis by orienting the 2-acetamido group and stabilizing the transition state. J Biol Chem, 2002, 277(42):40055-40065.

[46] Ling Z, Suits M D, Bingham R J, et al. The X-ray crystal structure of an Arthrobacter protophormiae endo-beta-N-acetylglucosaminidase reveals a (beta/alpha) catalytic domain, two ancillary domains and active site residues key for transglycosylation activity. J Mol Biol, 2009, 389(1):1-9.

[47] Abbott D W, Macauley M S, Vocadlo D J, et al. Streptococcus pneumoniae endohexosaminidase D, structural and mechanistic insight into substrate-assisted catalysis in family 85 glycoside hydrolases. J Biol Chem, 2009, 284(17):11676-11689.

[48] Umekawa M, Li C, Higashiyama T, et al. Efficient glycosynthase mutant derived from Mucor hiemalis endo-beta-N-acetylglucosaminidase capable of transferring oligosaccharide from both sugar oxazoline and natural N-glycan. J Biol Chem, 2010, 285(1):511-521.

[49] Huang W, Li C, Li B, et al. Glycosynthases enable a highly efficient chemoenzymatic synthesis of N-glycoproteins carrying intact natural N-glycans. J Am Chem Soc, 2009, 131(6):2214-2223.

[50] Fujita M, Shoda S, Haneda K, et al. A novel disaccharide substrate having 1,2-oxazoline moiety for detection of transglycosylating activity of endoglycosidases. Biochim Biophys Acta, 2001, 1528(1):9-14.

[51] Li B, Zeng Y, Hauser S, et al. Highly efficient endoglycosidase-catalyzed synthesis of glycopeptides using oligosaccharide oxazolines as donor substrates. J Am Chem Soc, 2005, 127(27):9692-9693.

[52] Zeng Y, Wang J, Li B, et al. Glycopeptide synthesis through endo-glycosidase-catalyzed oligosaccharide transfer of sugar oxazolines: probing substrate structural requirement. Chemistry, 2006, 12(12):3355-3364.

[53] Rising T W, Claridge T D, Moir J W, et al. Endohexosaminidase M: exploring and exploiting enzyme substrate specificity. Chembiochem, 2006, 7(8):1177-1180.

[54] Umekawa M, Huang W, Li B, et al. Mutants of Mucor hiemalis endo-beta-N-acetylglucosaminidase show enhanced transglycosylation and glycosynthase-like activities. J Biol Chem, 2008, 283(8):4469-4479.

[55] Yamamoto H, Asoh M, Murakami H, et al. Liposteroid (dexamethasone palmitate) therapy for West syndrome: a comparative study with ACTH therapy. Pediatr Neurol, 1998, 18(5):415-419.

[56] Li H, Li B, Song H, et al. Chemoenzymatic synthesis of HIV-1 V3 glycopeptides carrying two N-glycans and effects of glycosylation on the peptide domain. J Org Chem, 2005, 70(24): 9990-9996.

[57] Huang W, Groothuys S, Heredia A, et al. Enzymatic glycosylation of triazole-linked GlcNAc/Glc-peptides: synthesis, stability and anti-HIV activity of triazole-linked HIV-1 gp41 glycopeptide C34 analogues. Chembiochem, 2009, 10(7): 1234-1242.

[58] Huang W, Yang Q, Umekawa M, et al. Arthrobacter endo-beta-N-acetylglucosaminidase shows transglycosylation activity on complex-type N-glycan oxazolines: one-pot conversion of ribonuclease B to sialylated ribonuclease C. Chembiochem, 2010, 11(10):1350-1355.

[59] Amin M N, Huang W, Mizanur R M, et al. Convergent synthesis of homogeneous Glc(1)Man(9)GlcNAc(2)-protein and derivatives as ligands of molecular chaperones in protein quality control. J Am Chem Soc, 2011, 133(36):14404-14417.

[60] Huang W, Ochiai H, Zhang X, et al. Introducing N-glycans into natural products through a chemoenzymatic approach. Carbohydr Res, 2008, 343(17):2903-2913.

[61] Huang W, Wang D, Yamada M, et al. Chemoenzymatic synthesis and lectin array characterization of a class of N-glycan clusters. J Am Chem Soc, 2009, 131(49):17963-17971.

[1] ZHAO Xiao-yu,XU Qi-ling,ZHAO Xiao-dong,AN Yun-fei. Enhancing Lentiviral Vector Transduction Efficiency for Facilitating Gene Therapy[J]. China Biotechnology, 2021, 41(8): 52-58.
[2] QI Jia-long, GAO Rui-yu, JIN Shu-mei, GAO Fu-lan, YANG Xu, MA Yan-bing, LIU Cun-bao. Expression and Identification of Varicella-Zoster Virus Glycoprotein E and Immunogenicity Assay[J]. China Biotechnology, 2019, 39(8): 17-24.
[3] Ming-ying LI,Ren-jun WANG,Fun ZHANG,Yan CHI. The Prokaryotic Expression and Activity Analysis of the Fifth Domain of β2GPⅠ and Its Mutants or Short Peptide Fragments[J]. China Biotechnology, 2018, 38(8): 1-9.
[4] Yi HUANG,Xiao-yu LI,Fang TIAN,Xiao-hong QIAN,Wan-tao YING. Identification and Quantitative Study on Glycosylation Chain Modification of Antibody Drugs by Mass Spectrometry[J]. China Biotechnology, 2018, 38(1): 32-41.
[5] XU Yun-qiao, LI Ting-ting, WU Cai-e, FAN Gong-jian, LI Tong. Research Progress on the Methods of Deglycosylation of Glycoproteins[J]. China Biotechnology, 2017, 37(5): 97-106.
[6] MAO Hong-yan, MA Zheng-hai. Expression, Purification of Recombinant Herpes Simplex Virus 1 Glycoprotein D in E.coli and Identification of Its Immune Activity[J]. China Biotechnology, 2014, 34(11): 54-59.
[7] MA Zhong-rui, HAN Dong-lei, ZHAO Jun-fei, CHEN Meng-lin, CHEN Min. Recent Developments in N-linked Glycoproteins Production in Escherichia coli and Glycoprotein Vaccines[J]. China Biotechnology, 2013, 33(11): 92-98.
[8] SHI Rui-zan, HU Xiao-ling, FAN Yan-ying. Effects of c-fos Down-regulation via shRNA on P-gp-mediated Multidrug Resistance in Human Breast Cancer MCF-7/ADR Cells[J]. China Biotechnology, 2012, 32(12): 8-12.
[9] ZHANG Mei, WANG Xiao-bo, FU Yuan-hui, FANG Xuan, WANG Xing, ZHANG Ying, HE Jin-sheng. Primary Studies of Monoclonal Antibody Against Fusion Glycoprotein of Human Respiratory Syncytial Virus[J]. China Biotechnology, 2012, 32(02): 63-68.
[10] WANG Zheng-Mao, LI Lin, GUAN Wen-Yan, LI Huo-Xi. Expression of Herpes Simplex Virus Type I Glycoprotein B in Eukaryotic Cells and Analysis of Its Antigenicity and Immunogenicity[J]. China Biotechnology, 2010, 30(06): 8-13.
[11] . Isolation of Human Single Chain Antibody against Fusion Protein of Human Respiratory Syncytial Virus[J]. China Biotechnology, 2009, 29(09): 0-0.
[12] CAO Xiao-Gong- Mao-De-Zhi- Hu-Cheng-Jian- Lu-Mei-Fang- Han-Chao-Long- Wang-Xiao-Ye- He-Zhe- Wang-Chun-Ling. Preliminary Discussion on the Structure of a Novel Housefly Pupae Lectin[J]. China Biotechnology, 2009, 29(04): 93-97.
[13] XU Heng-Zhi- Zhang-Shou-Feng- Hu-Rong-Liang- Zhang-Le-Cui. Establishment of Transformed Mammalian Cell Lines Stably Expressing the Rabies Virus Glycoprotein[J]. China Biotechnology, 2009, 29(04): 46-50.
[14] WANG Hua-Lei Cheng-Yu WANG Song-Tao YANG Na FENG Xue-Xing ZHENG Qun LI Jian-Qing SU Ping ZHU Xian-Zhu XIA. Expression of a Recombinant Immunotoxin against Rabies Virus-infected Cells and Its Biological Activity[J]. China Biotechnology, 2008, 28(5): 1-5.
[15] . Advances in the Expression of Humanized Glycoprotein in Yeast[J]. China Biotechnology, 2007, 27(4): 120-125.